You are here

VINDICO NANOBIOTECHNOLOGY, INC.

Company Information
Address
A169, ASTeCC Bldg.,145 Graham Avenue
LEXINGTON, KY 40506-0286
United States


http://vindicopharma.com

Information

UEI: N/A

# of Employees: 3


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. A transfollicular nanovaccine against leishmaniasis

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): The World Health Organization estimates that over 350 million people are at risk of developing leishmaniasis and infection prevalence is 14 million people in the w ...

    SBIRPhase I2011Department of Health and Human Services National Institutes of Health
  2. Modulation of In Vivo Tumor Oxygenation via Polymersome-encapsulated Myoglobin

    Amount: $299,888.00

    DESCRIPTION (provided by applicant): Over 250,000 new cases of head and neck cancers (HNCs) and non-small cell lung cancers (NSCLCs) are diagnosed every year in the United States. At the time of diagn ...

    SBIRPhase I2011Department of Health and Human Services National Institutes of Health
  3. Fully Biodegradable Polymersome-encapsulated Hemoglobin as a Novel Nanoparticle-b

    Amount: $199,683.00

    DESCRIPTION (provided by applicant): Vindico NanoBioTechnology Inc. (Vindico) is developing a hemoglobin-based cellular oxygen therapeutic (blood substitute), NanoHeme, based on its proprietary na ...

    SBIRPhase I2010Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government